Search - tctmd.com

Displaying 1 - 20 of 63

Sort: Relevancy | Date

STS Spells Out Training Pathway for Robotic Surgery

News Conference News STS 2026

STS Spells Out Training Pathway for Robotic Surgery

Yael L. Maxwell

February 11, 2026

CVD Still the Leading Cause of Death and Disease Globally

News Daily News

CVD Still the Leading Cause of Death and Disease Globally

Michael O'Riordan

September 24, 2025

Global Burden of Degenerative Mitral Valve Disease Continues to Rise

News Conference News NY Valves 2025

Global Burden of Degenerative Mitral Valve Disease Continues to Rise

June 30, 2025

Underexpanded Acurate Valves Come With Higher Stroke Risk, Study Confirms

News Daily News

Underexpanded Acurate Valves Come With Higher Stroke Risk, Study Confirms

June 18, 2025

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

News Daily News EuroPCR 2025

Underexpanded Acurate neo2 Valves Tied to Worse Outcomes: ACURATE IDE

Michael O'Riordan

May 28, 2025

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

October 30, 2024

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

News Conference News HFSA 2024

EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER

October 03, 2024

News Industry News

Pi-Cardia Receives FDA Market Clearance for ShortCut™

October 01, 2024

Alain Cribier’s Death Mourned, His Legacy Celebrated Around the World

News Daily News

Alain Cribier’s Death Mourned, His Legacy Celebrated Around the World

February 19, 2024

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

News Conference News TCT 2023

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

Yael L. Maxwell

October 30, 2023

Newest MitraClip Iteration Performs Well in the Real World: EXPAND G4

News Conference News TCT 2022

Newest MitraClip Iteration Performs Well in the Real World: EXPAND G4

Yael L. Maxwell

September 23, 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

September 07, 2022

TCTMD’s Top 10 Most Popular Stories for June 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2022

July 04, 2022

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

News Conference News TVT 2022

Surgical Explant or Redo for TAVI Failures? Some Registry Insights

Michael O'Riordan

June 10, 2022

Gender-Related Differences in Clinical Presentation, Echocardiographic Characteristics, and Outcomes after MitraClip Therapy: Insights from the Global EXPAND Study

Presentation TVT 2022

Gender-Related Differences in Clinical Presentation, Echocardiographic Characteristics, and Outcomes after MitraClip Therapy: Insights from the Global EXPAND Study

Presenter: Nishtha Sodhi

June 09, 2022

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

News Conference News TVT 2022

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

Michael O'Riordan

June 09, 2022

One-Year Outcomes in Patients With Secondary MR Outside the COAPT Criteria: From the MitraClipTM Global EXPAND Study

Presentation TVT 2022

One-Year Outcomes in Patients With Secondary MR Outside the COAPT Criteria: From the MitraClipTM Global EXPAND Study

Presenter: Gilbert Tang

June 08, 2022

COVID-19 Had Broad Global Effects on CV Care, Review Affirms

News Daily News

COVID-19 Had Broad Global Effects on CV Care, Review Affirms

June 02, 2022

TCTMD’s Top 10 Most Popular Stories for May 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2022

June 01, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.